Abiopharma

Tilray Medical renforce sa présence sur le marché italien avec le lancement de Tilray Medical Italia et l’élargissement de son portefeuille de produits à base de cannabis thérapeutique

Tilray Medical rafforza la propria presenza sul mercato italiano con il lancio di Tilray Medical Italia e lampliamento del proprio portafoglio di prodotti a base di cannabis terapeutica

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials

OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software

Vistagen Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Vistagen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 16, 2026 - VTGN

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi

Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26

Class Action Filed Against Integer Holdings Corporation (ITGR) Seeking Recovery for Investors - Contact The Gross Law Firm

Jin Medical Announces the Official Commencement Date of Chuzhou Facility

PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101